Fibrinogen Human Terminated Phase 2 Trials for Coronary Artery Disease / Heart Valve Disease Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01283321RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery